Search

Displaying results 9681 - 9690 of 10000 in total
  1. Drug

    Iolopride I-123

    go.drugbank.com/drugs/DB20028
    Experimental

    The usage of the INN stem '-pride' in the name indicates that Iolopride I-123 is a sulpiride derivative and analogue. Iolopride I-123 has a monoisotopic molecular weight of 400.06 Da.

  2. Drug

    Ebaresdax

    go.drugbank.com/drugs/DB21496
    Investigational

    Ebaresdax is under investigation in clinical trial NCT05008835 (Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee).

  3. Drug

    Razpipadon

    go.drugbank.com/drugs/DB21542
    Investigational

    Razpipadon is under investigation in clinical trial NCT04958031 (A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy).

  4. Drug

    Zatonacaftor

    go.drugbank.com/drugs/DB21625
    Experimental

    The usage of the INN stem '-caftor' in the name indicates that Zatonacaftor is a Cystic fibrosis transmembrane regulator (CFTR) protein modulator, corrector, and amplifier.

  5. Drug

    Gestonorone

    go.drugbank.com/drugs/DB13230
    Experimental

    Gestonorone is often mistaken for gestonorone capproate which has a different chemical structure.

    Categories: Hormones and Related Agents, Genito Urinary System and Sex Hormones
  6. Drug

    Propenidazole

    go.drugbank.com/drugs/DB13319
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics
  7. Drug

    Arginine glutamate

    go.drugbank.com/drugs/DB13207
    Investigational

    Categories: Bile and Liver Therapy, Alimentary Tract and Metabolism
  8. Drug

    Protiofate

    go.drugbank.com/drugs/DB13632
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics
  9. Drug

    Onfekafusp alfa

    go.drugbank.com/drugs/DB16269
    Investigational

    Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).

    Categories: bifikafusp alfa and onfekafusp alfa, Antineoplastic and Immunomodulating Agents
  10. Drug

    Retezorogant

    go.drugbank.com/drugs/DB21592
    Experimental

    The usage of the INN stem '-rogant' in the name indicates that Retezorogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.